Survival Outcomes of Advanced Thyroid Cancer Enriched in Brain Metastases Following Treatment With Small Molecule Inhibitors

Wu, SS; Lamarre, ED; Scharpf, J; Prendes, B; Ku, JA; Silver, N; Burkey, B; Woody, N; Campbell, SR; Yilmaz, E; Koyfman, SA; Geiger, J

Geiger, J (通讯作者),Cleveland Clin, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA.

ENDOCRINE PRACTICE, 2023; 29 (11): 881

Abstract

Objective: Small molecule inhibitors (SMIs) are targeted therapies increasingly used in advanced thyroid carcinomas. This study aimed to evaluate the ......

Full Text Link